Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Nisshin OilliO Group is a leading Japanese corporation specializing in lipid science, edible oils, and specialty fats. Beyond its consumer food business, the company operates a significant Health Science division that develops and markets Medium Chain Triglycerides (MCTs) for clinical nutrition and therapeutic use. These MCT products are essential in managing conditions such as epilepsy through ketogenic diets, as well as addressing sarcopenia and malnutrition in aging populations. The company also produces high-purity fine chemicals, including fatty acid esters used as excipients and active ingredients in the pharmaceutical and cosmetic industries. With a history dating back to 1907, Nisshin OilliO leverages its deep expertise in oil processing to provide innovative nutritional solutions globally.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nisshin OilliO Group.